MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
143 hedge funds and large institutions have $657M invested in Merrimack Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 45 increasing their positions, 44 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less call options, than puts
Call options by funds: $1.79M | Put options by funds: $2.58M
Holders
143
Holding in Top 10
1
Calls
$1.79M
Puts
$2.58M
Top Buyers
| 1 | +$11.3M | |
| 2 | +$8.05M | |
| 3 | +$6.58M | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$5.38M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.57M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$5.24M | |
| 3 | -$3.16M | |
| 4 |
Jane Street
New York
|
-$2.83M |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$2.37M |